Hospital News and Research

RSS

Carfilzomib shows noteworthy responses and low side effects among multiple myeloma patients

The second-generation proteasome inhibitor carfilzomib is showing noteworthy response rates and low levels of adverse side effects among multiple myeloma patients in a phase II clinical trial, researchers reported today at the 51st Annual Meeting of the American Society of Hematology.

8 Dec 2009

Workforce Alliance receives $134,790 grant to fund workforce training program

Workforce Alliance was awarded a $134,790 grant by the State of Florida to fund a workforce training program aimed at meeting the high need for skilled health care workers in Palm Beach County.

8 Dec 2009

SonoSite launches new portable and compact ultrasound system in Europe

SonoSite Inc., the world leader and specialist in hand-carried ultrasound for the point-of-care, announced today that the company has completed the launch of the 6 pound NanoMaxx™ ultrasound tool in Europe.

7 Dec 2009

Two Brown University faculty members receive federal funding for new neuroscience research projects

Two Brown University faculty members have received federal funding for innovative new neuroscience research projects focusing on brain development in infants and bipolar disorder in children.

7 Dec 2009

Investigation: Temp firms often employ incompetent nurses

"Firms that supply temporary nurses to the nation's hospitals are taking perilous shortcuts in their screening and supervision, sometimes putting seriously ill patients in the hands of incompetent or impaired caregivers," ProPublica and The Los Angeles Times report. "Emboldened by a chronic nursing shortage and scant regulation, the firms vie for their share of a free-wheeling, $4-billion industry. Some have become havens for nurses who hopscotch from place to place to avoid the consequences of their misconduct."

7 Dec 2009

Cysteine-rich whey protein supplement may maintain or increase weight in advanced NSCLC patients

Immunotec Inc. announced today the enrollment of the first patient in the US Cancer trial of IMN 1207 being run at Beaumont Hospital's Community Clinical Oncology Program (CCOP) in Royal Oak, Michigan. The goal of the study is to determine the effect of IMN 1207, a cysteine-rich whey protein supplement, in preventing additional weight loss in patients with stage IV (advanced) non-small cell lung cancer.

7 Dec 2009

Masimo SpHb monitoring technology installed at Brookdale University Hospital and Medical Center

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that Brookdale University Hospital and Medical Center in Brooklyn, New York, has completed its system-wide conversion to Masimo SET pulse oximetry technology.

7 Dec 2009

'Never events' - medical errors - still continue 10 years after landmark report

Advocates and experts examine progress made since the Institute of Medicine released its landmark report that called for the elimination of medical errors, or "never events," ten years ago. Modern HealthCare interviews Helen Haskell, who founded the advocacy organization Mothers Against Medical Error, and examines progress and shortcomings: "Families are still losing loved ones to errors, Haskell explained during a recent conference hosted by Consumers Union. But the biggest difference in the past 10 years is, 'where once there was denial, we now have tireless leaders.'"

7 Dec 2009

Synta Pharmaceuticals announces study results of elesclomol

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced the results of a study evaluating the activity of elesclomol against acute myeloid leukemia (AML) cell lines and primary leukemic blast cells from AML patients, presented at the Annual Meeting of the American Society of Hematology (ASH) in New Orleans.

7 Dec 2009

UCB presents data on Vimpat AED at AES meeting

UCB today announced new findings on its antiepileptic drug (AED) Vimpat® that offer additional clinical evidence supporting the use of this AED as adjunctive therapy in adult patients with partial-onset seizures. Results of presented research demonstrate sustained efficacy in adult patients taking Vimpat® for up to three years, and a consistent long-term tolerability profile.

7 Dec 2009

Cubicle Curtain Factory to increase awareness of its innovative hospital privacy curtains

The Cubicle Curtain Factory has retained TransMedia Group to publicize the first major innovation in hospital privacy curtains in decades, the Simply 66 Snap System, which is already saving hospitals millions in maintenance costs.

7 Dec 2009

NEEBC names Amica Mutual Insurance as recipient of 2009 'Best Benefits Practice' award

The New England Employee Benefits Council (NEEBC) named Amica Mutual Insurance as a recipient of the 2009 "Best Benefits Practice" award, presented annually to the companies best exhibiting innovation and creativity in the planning and delivery of their employee benefit programs.

7 Dec 2009

TomTec introduces Image-Arena multimodality platform

TomTec the leading innovator for cardiac imaging presents its next generation Image-Arena™ multimodality platform for Image Analysis, Review and Data Management at the EuroEcho in Madrid.

7 Dec 2009

ICON, CMFT collaborate to develop translational medicine facilities on the MRI campus

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced details of its new translational medicine unit in Manchester, UK. The unit is the first deliverable from a collaborative agreement between ICON and the Central Manchester University Hospitals Foundation (CMFT) to develop purpose-built translational medicine facilities on the newly-developed Manchester Royal Infirmary (MRI) campus.

7 Dec 2009

Micromedex 2.0, the new version of clinical information system to be released

Thomson Reuters today announced the release of Micromedex 2.0, the newest version of its market-leading clinical information system.

7 Dec 2009

NHS teams up with international staff engagement specialists to improve patient care

The National Health Service (NHS), which manages 500 hospitals and over 1.5 million people in the UK, understands the value of an engaged staff: healthier and happier patients.

7 Dec 2009

Dabigatran etexilate prevents recurrent VTE with less bleeding than warfarin

Boehringer Ingelheim today announced very positive results from their landmark RE-COVER™ study – the most advanced trial programme assessing a novel oral anticoagulant in development for acute venous thromboemolism (VTE) treatment – presented at the American Society of Hematology Annual Meeting1 and published in the New England Journal of Medicine online.

7 Dec 2009

SU2C awards $9.68 million to support high-risk cancer research

Stand Up To Cancer (SU2C) announced today that it is awarding $9.68 million to support high-risk/high-reward cancer research conducted by 13 young scientists.

7 Dec 2009

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Blood clotting, or coagulation, is an important process that prevents excessive bleeding when a blood vessel is injured. Sometimes, however, clots form on the inside of vessels without an obvious injury or do not dissolve naturally, a potentially life-threatening situation requiring treatment.

7 Dec 2009

Updated results from phase III EXTEND clinical trial of pixantrone released

Cell Therapeutics, Inc. ("CTI") announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London during a session at the 2009 American Society of Hematology ("ASH") Annual Meeting updated results from the pivotal phase III EXTEND (PIX 301) clinical trial of pixantrone (the "PIX 301 EXTEND trial") in relapsed or refractory, aggressive non-Hodgkin's lymphoma ("NHL") patients who have failed 2 or more prior therapies.

7 Dec 2009

Hospital News and Research

Carfilzomib shows noteworthy responses and low side effects among multiple myeloma patients

Workforce Alliance receives $134,790 grant to fund workforce training program

SonoSite launches new portable and compact ultrasound system in Europe

Two Brown University faculty members receive federal funding for new neuroscience research projects

Investigation: Temp firms often employ incompetent nurses

Cysteine-rich whey protein supplement may maintain or increase weight in advanced NSCLC patients

Masimo SpHb monitoring technology installed at Brookdale University Hospital and Medical Center

'Never events' - medical errors - still continue 10 years after landmark report

Synta Pharmaceuticals announces study results of elesclomol

UCB presents data on Vimpat AED at AES meeting

Cubicle Curtain Factory to increase awareness of its innovative hospital privacy curtains

NEEBC names Amica Mutual Insurance as recipient of 2009 'Best Benefits Practice' award

TomTec introduces Image-Arena multimodality platform

ICON, CMFT collaborate to develop translational medicine facilities on the MRI campus

Micromedex 2.0, the new version of clinical information system to be released

NHS teams up with international staff engagement specialists to improve patient care

Dabigatran etexilate prevents recurrent VTE with less bleeding than warfarin

SU2C awards $9.68 million to support high-risk cancer research

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Updated results from phase III EXTEND clinical trial of pixantrone released

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News